New Delhi, Jan. 29 -- Piramal Pharma Ltd is starting to see early signs of a recovery in its contract manufacturing business, with order inflows picking up on the back of improved biopharma funding an... Read More
New Delhi, Jan. 27 -- India's landmark free trade deal with the European Union, finalised on Tuesday, includes significant tariff cuts on exports of pharmaceutical products as well as optical, medical... Read More
New Delhi, Jan. 25 -- The US has formally withdrawn from the World Health Organization (WHO), a year after President Donald Trump signed an executive order to begin the process. The move deprives the... Read More
New Delhi, Jan. 24 -- Sun Pharmaceutical Industries Ltd has received the Drugs Controller General of India's (DCGI) approval to make and market a generic version of semaglutide injection for weight ma... Read More
Mumbai, Jan. 23 -- Contract drug research and manufacturing firm Syngene International Ltd has lowered its full-year revenue guidance from mid-single digit growth to negative 2-3%, as destocking of a ... Read More
Mumbai, Jan. 23 -- Sun Pharmaceutical Industries Ltd has received the Drugs Controller General of India's (DCGI) approval to make and market a generic version of semaglutide injection for weight manag... Read More
MUMBAI, Jan. 22 -- Zydus Lifesciences has launched its biosimilar of anti-cancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the ... Read More
New Delhi, Jan. 21 -- Hyderabad-based Dr Reddy's Laboratories beat street estimates in the third quarter, reporting revenue of Rs.8,726.8 crore and profit after tax (PAT) of Rs.1,210 crore, with stead... Read More
New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More
New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More